Intralipid 20% and Furosemide drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Intralipid 20% (soybean oil) and Furosemide (furosemide). Common drug interactions include blister among females and epidermal necrolysis among males.

The phase IV clinical study analyzes what interactions people have when they take Intralipid 20% and Furosemide. It is created by eHealthMe based on reports of 12 people who take the same drugs from the FDA, and is updated regularly.

What is Intralipid 20%?

Intralipid 20% has active ingredients of soybean oil. eHealthMe is studying from 157 Intralipid 20% users. Check the latest studies of Intralipid 20%.

What is Furosemide?

Furosemide has active ingredients of furosemide. It is often used in fluid retention. eHealthMe is studying from 316,095 Furosemide users. Check the latest studies of Furosemide.



On Jul, 12, 2026

12 people who take Intralipid 20% and Furosemide together, and have interactions are studied.

Intralipid 20% and Furosemide drug interactions.

What are the common drug interactions of Intralipid 20% and Furosemide, by gender? *:

female:

  1. Blister (small pocket of fluid within the upper layers of the skin caused by forceful rubbing (friction), burning, freezing, chemical exposure)
  2. Epidermal necrolysis (skin condition that is usually caused by a reaction to drugs)
  3. Gastroenteritis (inflammation of stomach and intestine)
  4. Graft versus host disease (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the body)
  5. Mucosal inflammation (infection of mucous membrane)
  6. Pyrexia (fever)
  7. Rash erythematous (redness of the skin)
  8. Sepsis (a severe blood infection that can lead to organ failure and death)
  9. Stevens johnson syndrome (an immune-complex-mediated hypersensitivity disorder. it ranges from mild skin and mucous membrane lesions to a severe)
  10. Abscess (pus)

male:

  1. Epidermal necrolysis (skin condition that is usually caused by a reaction to drugs)
  2. Multi-organ failure (multisystem organ failure)
  3. Rash macular (small, flat red spots)
  4. Sepsis (a severe blood infection that can lead to organ failure and death)
  5. Bronchospasm (spasm of bronchial smooth muscle producing narrowing of the bronchi)
  6. C-reactive protein increased
  7. Chills (felling of cold)
  8. Pyrexia (fever)
  9. Rash maculo-papular (red area on the skin that is covered with small confluent bumps)
  10. Tachyarrhythmia (disturbance of the heart rhythm in which the heart rate is abnormally increased)

What are the common drug interactions of Intralipid 20% and Furosemide, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

  1. Blister (small pocket of fluid within the upper layers of the skin caused by forceful rubbing (friction), burning, freezing, chemical exposure)
  2. Conjunctivitis (pink eye)
  3. Dermatitis (inflammation of the skin resulting from direct irritation by an external agent or an allergic reaction to it)
  4. Epidermal necrolysis (skin condition that is usually caused by a reaction to drugs)
  5. Multi-organ failure (multisystem organ failure)
  6. Pruritus (severe itching of the skin)
  7. Rash maculo-papular (red area on the skin that is covered with small confluent bumps)
  8. Skin ulcer
  9. Stevens johnson syndrome (an immune-complex-mediated hypersensitivity disorder. it ranges from mild skin and mucous membrane lesions to a severe)

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Blister (small pocket of fluid within the upper layers of the skin caused by forceful rubbing (friction), burning, freezing, chemical exposure)
  2. Conjunctivitis (pink eye)
  3. Epidermal necrolysis (skin condition that is usually caused by a reaction to drugs)
  4. Graft versus host disease (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the body)
  5. Multi-organ failure (multisystem organ failure)
  6. Rash erythematous (redness of the skin)
  7. Rash macular (small, flat red spots)
  8. Sepsis (a severe blood infection that can lead to organ failure and death)
  9. C-reactive protein increased
  10. Pneumonia

50-59:

  1. Rash erythematous (redness of the skin)
  2. Sepsis (a severe blood infection that can lead to organ failure and death)
  3. Stevens johnson syndrome (an immune-complex-mediated hypersensitivity disorder. it ranges from mild skin and mucous membrane lesions to a severe)
  4. Abscess (pus)
  5. Acute circulatory failure (shock)
  6. Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection)
  7. Aplasia (defective development or congenital absence of an organ or tissue)
  8. Aspartate aminotransferase increased
  9. Blood creatine phosphokinase increased
  10. Bronchopulmonary aspergillosis (lung disorder caused by aspergillus fungi)

60+:

  1. Bronchospasm (spasm of bronchial smooth muscle producing narrowing of the bronchi)
  2. Chills (felling of cold)
  3. Tachyarrhythmia (disturbance of the heart rhythm in which the heart rate is abnormally increased)
  4. Tachycardia (a heart rate that exceeds the range of 100 beats/min)

What are the existing conditions these people have? *

  1. Blood Immunoglobulin G Decreased: 2 people, 16.67%

* Approximation only. Some reports may have incomplete information.

Do you take Intralipid 20% and Furosemide?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Intralipid 20% and Furosemide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Intralipid 20%:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Furosemide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Intralipid 20% and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Furosemide and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on soybean oil and furosemide (the active ingredients of Intralipid 20% and Furosemide, respectively), and Intralipid 20% and Furosemide (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: